Benzinga | May 17, 2021 04:34PM EDT

Aytu BioScience Q3 EPS $(0.43) Misses $(0.31) Estimate, Sales $13.48M Miss $14.06M Estimate

Aytu BioScience (NASDAQ:AYTU) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.31) by 38.71 percent. This is a 186.67 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $13.48 million which missed the analyst consensus estimate of $14.06 million by 4.11 percent. This is a 65.30 percent increase over sales of $8.16 million the same period last year.